ClinicalTrials.gg
RecruitingNCT06218472EVA-FAMUpdated Jan 29, 2026

Assessment of the Impact of Early Treatment for Anorexia Nervosa in a Day Hospital on Food Symptomatology, the Outcome of Young Patients, and the Family Experience

An observational study in Anorexia Nervosa, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-29.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

How we know

From the registry’s dates

  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
164
Ages
12 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Anorexia Nervosa by Assistance Publique - Hôpitaux de Paris — 4 open to participants now, 5 under way, none of them phase 3. Anorexia Nervosa · Assistance Publique - Hôpitaux de Paris.

Started
2024
with 2 others
Observational
9 of 14
4 open now
Registered
12th of 14
by date

Among the 14 studies in Anorexia Nervosa by Assistance Publique - Hôpitaux de Paris, this one is one of 3 that started in 2024, is one of 9 observational ones, and was the 12th registered.

Anorexia Nervosa

471 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.

Browse Anorexia Nervosa studies →

Open to participants now

4 of the 14 studies in Anorexia Nervosa by Assistance Publique - Hôpitaux de Paris are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 82 Anorexia Nervosa studies recruiting now, 18 (22%) set no upper age limit and 60 (73%) stop at 75 or younger; 48 take children under 18; 26 take healthy volunteers.

This study: 12 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Anorexia Nervosa by Assistance Publique - Hôpitaux de Paris, or all of them as a file.
02

Study summary

During the management of chronic illnesses, the day hospital (DH) serves as a brief and effective alternative to traditional hospitalization, offering access to multidisciplinary care. Indeed, patients can benefit from a range of therapeutic tools provided by a multidisciplinary care team while remaining in their living environment. Numerous structures exist for the management of eating disorders, but primarily for severe cases, often following hospitalization, before transitioning to outpatient care. There is no alternative for the initial management of these patients.

The DH for the evaluation and early intervention in recent forms of anorexia nervosa at Maison de Solenn serves as a rapid entry point to specialized care. It allows for a thorough assessment and sustained management of eating disorders. Our hypothesis is that a multidisciplinary, intensive, and early intervention for patients with anorexia nervosa and their families in a day hospital would improve the short, medium, and long-term prognosis of the disease compared to conventional multidisciplinary outpatient care. It would also enhance the family's experience of this pathology and their coping skills.

Read the detailed description

The patients recruited will come from the active consultation file of the inclusion center (spontaneous consultations, referrals from healthcare professionals, etc.), whether they have had an initial consultation or not. All patients admitted to day hospital during the study period who meet the inclusion criteria will be considered. A first evaluation consultation for mental anorexia will be conducted for all patients, including a somatic and psychological assessment, as well as a consultation with a dietitian. If eligible, the patient and their family will be offered participation in day hospital (for the next session or the following one, depending on availability). In case of refusal, regardless of the reason (parents' availability, excessive distance from home, lack of motivation, etc.), patients will receive regular care in outpatient consultations. For the qualitative study, parents participating in day hospital for their adolescent will be offered inclusion in this research protocol.

The inclusion of young patients will take place over two calendar years (24 consecutive months) for the characterization of the active file. The study will continue for 5 years after the inclusion of the last patient in the study to investigate the outcome. In total, data collection for this research will last a maximum of 84 months (24 months of recruitment and a 5-year follow-up).

Visit 1 - Inclusion: collection of non-oppositions, initial clinical evaluation, then proposal to participate in the day hospital program:

  • In case of refusal or impossibility of the day hospital program: multidisciplinary follow-up "as usual" at the consultation center (outpatient group).
  • In case of acceptance of the day hospital program (day hospital group): scheduling of 10 to 12 sessions over 12 weeks during a program session, followed by a new evaluation at the end of the program. Outpatient follow-up thereafter.

Outpatient follow-up consists of appointments with the psychiatrist, pediatrician, and dietitian, on average, every month.

Follow-up visits:

  • Day hospital group only - at approximately 12 weeks: Visit 1bis: clinical evaluation at the end of the program + semi-structured interviews with parents
  • Visit 2 - at 6 months: evaluations, with a search for clinical events + semi-structured interview with patients (either at V2 or V3)
  • Visit 3 - at 12 months: evaluations, with a search for clinical events + semi-structured interview with patients (either at V2 or V3)

End of research visit:

- Visit 4 - at 5 years: evaluations, with a search for clinical events

Visits V2, V3, and V4 can be conducted by phone. Visit V4, not necessarily planned as part of the adolescent's follow-up, may be added to care if necessary. It can be conducted by phone, depending on the adolescent's choice.

For participants who have taken part in the day hospital program or outpatient follow-up before the implementation of this protocol and who meet the inclusion criteria, the information sheet will be provided to them during a consultation by an investigator, and non-opposition will be obtained at the next consultation. In case of agreement to participate, data from already conducted visits will be collected retrospectively, and patients will then be contacted for the yet-to-be-performed assessment visits at 6 months (if applicable), 1 year (if applicable), and 5 years.

03

Conditions studied

  • Anorexia Nervosa

Browse trials for

Keywords

  • Anorexia nervosa
  • Family-based treatment
  • Day hospital
  • Early intervention
  • Parental experience
04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

This study will include patients of any gender aged 12 to 18 years and their parents, seen in consultation for anorexia nervosa at the pedopsychiatric unit of the Cochin Hospital, Paris, France.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adolescents in the age range of 12-18 years and their parents,
  • First-time consultation at the MDA for anorexia nervosa (according to ) evolving for less than 12 months,
  • Adolescents with clinical characteristics suitable for DH care.

Exclusion criteria

Exclusion Criteria:

  • Parents and/or children who do not speak French or cannot read or write,
  • Patients who have been followed by an eating disorder specialist in the past 12 months (at the MDA or elsewhere) or previously hospitalized for anorexia nervosa,
  • Patients who have undergone family therapy in the past,
  • Patients with less than 13 kg/m2 for those under 14 years old, or less than 14 kg/m2 for those over 14 years old at the initial assessment,
  • Patients with a major psychiatric comorbidity or a metabolic condition interfering with eating or its regulation,
  • Patients and families in a crisis situation requiring immediate hospitalization.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
164 participants (estimated)
Patient registry
No

Groups and cohorts

  • Day hospital patient

    Acceptance of the DH program (DH group): scheduling of 10 to 12 sessions over 12 weeks during a program session, followed by a reassessment at the end of the program. Outpatient follow-up thereafter.

    Other: Day Hospital Treatment

  • Outpatient

    Refusal or inability to participate in the DH program: multidisciplinary follow-up "as usual" within the service (outpatient group).

    Other: Multidisciplinary follow-up "as usual" within the service

  • Parents

    Other: Conduct semi-structured qualitative interviews

Interventions

  • OtherDay Hospital Treatment

    Scheduling of 12 half-day sessions per week, alternating between sessions with only the patients or involving the entire family. Close medical monitoring and multidisciplinary interventions during sessions (pediatrician, psychiatrist, dietitian, recovered former patients...).

    Also known as: Family based treatment

  • OtherMultidisciplinary follow-up "as usual" within the service

    Multidisciplinary follow-up "as usual" within the service

  • OtherConduct semi-structured qualitative interviews

    Conduct semi-structured qualitative interviews

06

What researchers measure

Primary outcomes

  1. Occurrence of one or more clinical events

    Occurrence of one or more clinical events indicative of the progression of this disease (hospitalization, emergency room visits, major decompensation) at 1 year. Evaluate the impact of early intervention in DH on the clinical progression of the disease compared to the usual outpatient care.

    Time frame: 1 year after inclusion

Secondary outcomes

  1. Occurrence of one or more clinical events

    Occurrence of one or more clinical events indicative of the progression of this disease (hospitalization, emergency room visits, major decompensation) at 5 years in both care groups. Evaluate the long-term impact of early intervention in DH on the clinical progression of the disease, compared to the usual outpatient care.

    Time frame: 5 years after inclusion

  2. Conduct semi-structured qualitative interviews

    Conduct semi-structured qualitative interviews with parents after participation in the DH program. Explore the experience and perspectives of families participating in a new day hospital care program for adolescents with recent anorexia nervosa.

    Time frame: After DH termination = 12 weeks after inclusion

  3. Satisfaction questionnaire CSQ-8 (Consumer satisfaction questionnaire)

    Satisfaction questionnaire at the end of DH care. Assess the satisfaction level of the patient and their parents regarding DH care. The range of possible scores is 8-32; (32 = higher satisfaction = better outcome, 8 = lower satisfaction)

    Time frame: After DH termination = 12 weeks after inclusion

  4. Clinical characteristics collection

    Initial clinical characteristics at the time of inclusion. Determine predictive factors for the outcome at the end of the intervention and in the long term.

    Time frame: Inclusion

  5. Socio-demographic characteristics collection

    Initial socio-demographic characteristics at the time of inclusion. Determine predictive factors for the outcome at the end of the intervention and in the long term.

    Time frame: Inclusion

  6. Semi-structured interviews (DH program group)

    Semi-structured interviews 6 to 12 months after their discharge from day hospital (visit 2 or 3 - DH program group), to assess the impact on the evolution of symptomatology of the experience lived by adolescents in the care within the framework of this early management system for anorexia nervosa (HDJ group).

    Time frame: From 6 to 12 months after the end of day hospital (visit 2 or 3 - DH program group)

07

Study locations

1 of 1 sites recruiting
  • Maison de Solenn Maison des Adolescents, Cochin Hospital
    Paris, IDF 75014, France
    Recruiting
    • Corinne BLANCHET, MD, PhD · Contactcorinne.blanchet@aphp.fr
    • Thomas DIOT, MD · Contactthomas.diot@aphp.fr
    • Corinne BLANCHET, MD, PhD · Principal investigator
    • Alexandra LOISEL, MD, PhD · Sub investigator
    • Aurélie HARF, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Feb 2028, 48 months after the start.

Of 56 non-industry observational studies under Anorexia Nervosa, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 72. This study's planned 48 months is above that.

Counting every sponsor, half of 56 studies reached it within 38 months; a quarter within 16 and three quarters within 72.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 8, 2024
First posted
Jan 23, 2024
StartActual
Feb 19, 2024
Primary completionEst.
Feb 2028
CompletionEst.
Apr 2032
Last update
Jan 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06218472
Collaborators
URC-CIC Paris Descartes Necker Cochin
Responsible party
Sponsor
First posted
Jan 23, 2024
Start date
Feb 19, 2024
Primary completion
Feb 2028 (estimated)
Completion
Apr 2032 (estimated)
Last update
Jan 29, 2026

Study contacts

Corinne BLANCHET, MD, PhD
Contact
corinne.blanchet@aphp.fr
00 33 1 58 41 24 24
Marie BENHAMMANI-GODARD
Contact
marie.godard@aphp.fr
00 33 1 58 41 11 90

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion